These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36722655)

  • 1. Molecular basis of the different effects of procainamide and N-acetylprocainamide on the maximum upstroke velocity and half-decay time of the cardiac action potential in guinea pig papillary muscle.
    Sigler W; Oliveira AC
    Braz J Med Biol Res; 2023; 56():e12073. PubMed ID: 36722655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic interactions of procainamide and N-acetylprocainamide in isolated canine cardiac Purkinje fibers.
    Coyle JD; Carnes CA; Schaal SF; Muir WW
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):197-205. PubMed ID: 1381010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the pharmacokinetic and pharmacodynamic properties of procainamide and N-acetylprocainamide.
    Atkinson AJ; Ruo TI; Piergies AA
    Angiology; 1988 Jul; 39(7 Pt 2):655-67. PubMed ID: 2457345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of the electrophysiological and antiarrhythmic properties of the N-acetyl metabolite of procainamide with plasma and tissue drug concentrations in the dog.
    Bagwell EE; Walle T; Drayer DE; Reidenbert MM; Pruett JK
    J Pharmacol Exp Ther; 1976 Apr; 197(1):38-48. PubMed ID: 1263131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid assessment of rate and antiarrhythmic drug effect on the myocardium using asymmetric biphasic pulse stimulation.
    Furukawa T; Herscovici H; Desai T; Sampsell R; Nogami A; Moroe K; Rozanski JJ; Lister JW
    Pacing Clin Electrophysiol; 1989 Jan; 12(1 Pt 1):52-64. PubMed ID: 2464811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro antiarrhythmic and arrhythmogenic effects of N-acetyl procainamide.
    Dangman KH; Hoffman BF
    J Pharmacol Exp Ther; 1981 Jun; 217(3):851-62. PubMed ID: 6164783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiarrhythmic potency of procainamide and N-acetylprocainamide in rabbits.
    Minchin RF; Ilett KF; Paterson JW
    Eur J Pharmacol; 1978 Jan; 47(1):51-6. PubMed ID: 618730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmia control by selective lengthening of cardiac repolarization: role of N-acetylprocainamide, active metabolite of procainamide.
    Singh BN; Feld G; Nademanee K
    Angiology; 1986 Dec; 37(12 Pt 2):930-8. PubMed ID: 2433967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated mammalian and human cardiac tissues.
    Pankucsi C; Bányász T; Magyar J; Gyönös I; Kovács A; Varró A; Szénási G; Nánási PP
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):398-405. PubMed ID: 9089672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylprocainamide induced changes in refractoriness and monophasic action potentials of the dog heart in situ.
    Amlie JP; Landmark K
    Cardiovasc Res; 1981 Mar; 15(3):159-63. PubMed ID: 6167356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac anticholinergic effects of procainamide and its N-acetylated metabolite: experimental pharmacological and radioligand binding studies.
    Boucher M; Chassaing C; Laborde P; Breysse C; Herbet A
    J Auton Pharmacol; 1998 Apr; 18(2):83-7. PubMed ID: 9730262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discordant influences of infarct healing on the electrophysiologic effects of procainamide and N-acetylprocainamide.
    Nelson SD; Coyne KS; Meimer J
    J Pharmacol Exp Ther; 1995 Apr; 273(1):315-9. PubMed ID: 7536244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of N-acetylprocainamide.
    Atkinson AJ; Ruo TI
    Angiology; 1986 Dec; 37(12 Pt 2):959-67. PubMed ID: 2433970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New anti-arrhythmia drug. III. Comparative studies of the effects of N-propionylprocainamide, procainamide and N-acetylprocainamide on hemodynamics and cardiac blood flow].
    Kusowska J; Polakowski P
    Acta Pol Pharm; 1989; 46(2):187-94. PubMed ID: 2483600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic effects of N-acetylprocainamide in man: comparison with other antiarrhythmic drugs.
    Josephson MA; Singh BN
    Angiology; 1986 Dec; 37(12 Pt 2):950-8. PubMed ID: 2433969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs.
    Wu B; Sato T; Kiyosue T; Arita M
    Cardiovasc Res; 1992 Nov; 26(11):1095-101. PubMed ID: 1291087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of procainamide and its N-acetylated metabolite in conscious dogs with atrioventricular block: plasma concentration-response relationships.
    Boucher M; Dubray C; Paire M; Duchêne-Marullaz P
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):562-7. PubMed ID: 2447406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procainamide: clinical pharmacology and efficacy against ventricular arrhythmias.
    Giardina EG
    Ann N Y Acad Sci; 1984; 432():177-88. PubMed ID: 6084435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of N-acetylprocainamide and sotalol on ion currents in isolated guinea-pig ventricular myocytes.
    Komeichi K; Tohse N; Nakaya H; Shimizu M; Zhu MY; Kanno M
    Eur J Pharmacol; 1990 Oct; 187(3):313-22. PubMed ID: 1705889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.
    Roden DM; Reele SB; Higgins SB; Wilkinson GR; Smith RF; Oates JA; Woosley RL
    Am J Cardiol; 1980 Sep; 46(3):463-8. PubMed ID: 6158263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.